What do oncology MSL’s do?

Quote

Anonymous

Guest
Seriously I need help understanding the day to day. My company in no longer sponsoring investigator initiated trials so they are not working on those. I have three major research based academic institutions that never request an MSL nor do they meet with them. Any off label or AE questions are handled by our medical affairs “hotline” which is not manned with MSL’s so I’m really am having a tough time wondering how they fill a week. We only hire PharmD’s, MD’s, or PhD’s in our MSL positions so clearly they are smart people but I can’t imagine what they do day to day. Again this is not a “are MSL’s valuable” argument, I’m sure they are or companies wouldn’t have them, but again what do they do on a day to day week to week basis. My MSL cover an entire coast and they are almost always home so it’s not like they are out “making the rounds”.

Thanks for any input.
 






What company is this?

They could be doing sales training, speaker training for promotional program content, setting up advisory boards to get KOL input, or reviewing medical communications similar to other med affairs employees.

Who is providing these services to your company?

MSLs wear many hats depending on the company and product lifecycle(s).
 






Anonymous said:
What company is this?

They could be doing sales training, speaker training for promotional program content, setting up advisory boards to get KOL input, or reviewing medical communications similar to other med affairs employees.

Who is providing these services to your company?

MSLs wear many hats depending on the company and product lifecycle(s).
Click to expand...

Sales training is handled by training, KOL’s are handled by our med affairs people who are all oncologist MD’s, Ad boards are conducted by marketing(MSL’s do attend), speaker training is done by an MD who has been on our speakers board for a few years and is coordinated by marketing. Lit reviews are done by our med affairs team and coordinated with marketing and training/(and compliance of course!) That’s what I’m saying our MSL’s are basically on retainer for when they are needed which is few and far between in this day and age. When we used to do IST’s they were busier but since we stopped sponsoring them I really have no idea what they do to fill a week of work. Again I’m not bashing them but I have major academic centers and they have zero interest in talking to a MSL, they want to talk to the Med Affairs people about landing the next clinical trial and they know that the field base MSL has little to no influence over that.
 












Anonymous said:
Seriously I need help understanding the day to day. My company in no longer sponsoring investigator initiated trials so they are not working on those. I have three major research based academic institutions that never request an MSL nor do they meet with them. Any off label or AE questions are handled by our medical affairs “hotline” which is not manned with MSL’s so I’m really am having a tough time wondering how they fill a week. We only hire PharmD’s, MD’s, or PhD’s in our MSL positions so clearly they are smart people but I can’t imagine what they do day to day. Again this is not a “are MSL’s valuable” argument, I’m sure they are or companies wouldn’t have them, but again what do they do on a day to day week to week basis. My MSL cover an entire coast and they are almost always home so it’s not like they are out “making the rounds”.

Thanks for any input.
Click to expand...

Basically oncology MSLs do what all MSLs do; sit at home all day and masturbate to gay midget porn.
 






Anonymous said:
Sounds like you have a mature product line.
If your MSLs are smart they'll be supporting managed markets with field HEOR studies...
Click to expand...

Actually it is not mature at all. One product a few indications and few compendia listings, and a few indications on the way. What I have found in my 17 years in oncology is that in today’s landscape, now more than ever, the big research institutions want to deal with the medical directors, and we have a few big name, well known medical directors so when the KOL’s need something they generally go to the top and not deal with a field based MSL. They’ll call the MSL if they need slides for a talk but any one could handle those requests. We have plenty of HEOR studies but the MSL time need for those is minimal. We have no need for managed markets support as this is not a formula controlled drug. Everyone has access to it.
 












Top Bottom
Back
Quote